STEP 1 — Semaglutide 2.4 mg
Wilding et al., New England Journal of Medicine, 2021
Adults with overweight or obesity lost an average of 14.9% of body weight at 68 weeks versus 2.4% on placebo, with 86% losing at least 5%.

Self-injectable GLP-1 weight-loss medications delivered to your door — with comprehensive labs, a virtual medical consultation, and a plan designed for long-term success.

Our medical weight-loss program combines modern GLP-1 medications with personalized medical oversight to help you lose weight and keep it off. We start with comprehensive lab testing and a virtual consultation with a medical provider to determine your eligibility and design a plan that fits your body and goals.
Once approved, your monthly supply of weight-loss injections is shipped directly to you — everything you need for convenient, at-home treatment. Semaglutide with Glycine or Vitamin B12 starts at $199/month, while Tirzepatide with Glycine or Niacinamide starts at $299/month. Lab costs are covered by most PPO insurance plans.

"A private plan. Results that feel entirely like you."
Bloodwork to determine eligibility and create a safe, effective protocol.
A one-on-one visit with a medical provider to review your history and goals.
Your prescription medication and supplies delivered directly to your door.
Semaglutide or Tirzepatide compounded with Glycine, B12, or Niacinamide.
Regular check-ins to adjust dosing, manage progress, and support long-term maintenance.
Both are weekly self-administered injections that quiet appetite and improve metabolic health — the difference is how they work. Semaglutide activates one hormone pathway (GLP-1). Tirzepatide activates two (GLP-1 and GIP), which in head-to-head research has produced greater average weight loss. Your provider will recommend the right one based on your labs, history, tolerance, and goals.
Single-pathway GLP-1 · from $199/month
Dual-pathway GLP-1 + GIP · from $299/month

GLP-1 therapy is among the most rigorously studied areas in modern metabolic medicine. A snapshot of the landmark trials behind our protocols.
Wilding et al., New England Journal of Medicine, 2021
Adults with overweight or obesity lost an average of 14.9% of body weight at 68 weeks versus 2.4% on placebo, with 86% losing at least 5%.
Jastreboff et al., New England Journal of Medicine, 2022
Average weight reduction of 15.0%, 19.5% and 20.9% at 72 weeks across the 5 mg, 10 mg and 15 mg doses versus 3.1% on placebo.
New England Journal of Medicine, 2025
In a direct comparison, tirzepatide produced roughly 20.2% average weight loss versus 13.7% for semaglutide at 72 weeks.
Lincoff et al., New England Journal of Medicine, 2023
Semaglutide reduced major adverse cardiovascular events by 20% in adults with obesity and existing cardiovascular disease — benefits reaching beyond the scale.
Rubino et al., JAMA, 2021
Continuing semaglutide sustained weight loss, while stopping led to regain — reinforcing why ongoing medical supervision is part of our program.
Frías et al., New England Journal of Medicine, 2021
Tirzepatide produced greater reductions in A1C and body weight than semaglutide 1 mg in adults with type 2 diabetes.
Study results are averages from published clinical trials and are not a promise of individual outcomes. Eligibility, dosing and expectations are determined by your medical provider.

GLP-1 medications help quiet appetite and food noise so healthier choices feel easier.
Supports blood sugar regulation, energy, and markers of metabolic wellness.
Designed for steady, sustainable progress rather than quick fixes.
No clinic visits required — medication arrives monthly and is self-administered.
Every step is guided by licensed medical providers, from lab review to dosing adjustments.

Your program begins with lab testing and a virtual consultation. A medical provider reviews your results, determines eligibility, and prescribes a custom GLP-1 medication such as Semaglutide or Tirzepatide. Your first monthly injection kit is shipped directly to you with instructions for safe, simple self-injection. Follow-up visits monitor progress and adjust dosing as needed.

Stay consistent with your weekly injections and follow the nutrition and lifestyle guidance provided. Regular check-ins help manage side effects, adjust dosing, and plan for long-term maintenance. Most guests notice reduced appetite within the first few weeks, with steady weight loss continuing over several months.

We believe weight loss should be safe, supported, and realistic. Our program combines clinical oversight with the convenience of at-home delivery, so you can focus on building habits that last — not just numbers on a scale.
We proudly serve the Antelope Valley — including Palmdale and Lancaster — from our home in Quartz Hill, California.
We offer physician-prescribed GLP-1 medications including Semaglutide with Glycine or Vitamin B12, and Tirzepatide with Glycine or Niacinamide.
Semaglutide starts at $199/month and Tirzepatide starts at $299/month. Lab costs are billed separately and are typically covered by most PPO insurance plans.
Complete lab testing, attend a virtual consultation, receive your monthly injection kit by mail, and self-administer the medication at home. Ongoing follow-up keeps your protocol on track.
Yes — the program is physician-supervised, includes lab review, and follows current clinical guidelines. A medical provider determines your eligibility before prescribing.
Results vary by individual. Most participants experience steady, meaningful weight loss over several months when following the protocol consistently.